USPTO serial 98599574
INEXELL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 3, 2025
- Examiner
- GOLDEN, JAMES B
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with INEXELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca, and Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development in the field of stem cells, cell therapy, personalized medicine and biotechnology; pharmaceutical research and development in the field of cell therapy and personalized medicine; scientific laboratory services; scientific study and research in the field of activity, toxicity, metabolism and mechanism of action of molecules; provision of information related to scientific research in the field of cells, cell therapy, personalized medicine, pharmacology, toxicology and biotechnology; Research and development of cell therapy and personalized medicine products and treatments; Laboratory research services in the field of cell therapy, personalized medicine, pharmacology and toxicology; Chemical research and development; Provision of information and data related to research and development in the field of cell therapy, personalized medicine, pharmacology and toxicology; Biological, clinical and medical research in the field of cell therapy, personalized medicine, pharmacology and toxicology; Biological, clinical and medical research in the field of cell therapy, personalized medicine, pharmacology and toxicology; Chemical, biological, bacteriological and biochemical analysis services; Medical and scientific research, namely, conducting clinical trials for others in the field of cell therapy and personalized medicine; provision of medical and scientific research information regarding the results of clinical trials in the field of cell therapy and personalized medicine; design and development of biological and chemical reagents and assays; Design and development of cellular models, cell lines, cell culture, and cell-based assays; Design and development of chemical and biological reagents for cell culture, production, analysis, sorting and processing; Consulting services related to the monitoring of medical or laboratory diagnostic protocols, consulting services related to the calibration of scientific apparatus and instruments, consulting services relating to the calibration of medical or laboratory diagnostic devices and instruments, consulting services for the development of chemical and biological reagents; Scientific research services related to cellular models, cell lines, cell culture, and cell-based assays for the medical field; Scientific research services related to cellular products cellular models, cell lines, cell culture, and cell-based assays for toxicology and pharmacology studies | ACTIVE | — |
| 044 | Medical and biological analysis services relating to the treatment of people with cell therapy; providing medical information in the form of medical reports in the field of cell therapy and personalized medicine; Medical and biological information services in the field of cell therapy and personalized medicine; Public health advice on cell therapy and personalized medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Satt Ouest Valorisation
- Other trademarks owned by Satt Ouest Valorisation
- Other trademarks owned by Satt Ouest Valorisation
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named INEXELL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 3, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 14, 2025 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| May 6, 2025 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 6, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 13, 2025 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2024 | NWAP | NEW APPLICATION ENTERED | — |